Fundamentals of Pharmaceutical Nanoscience
The emerging discipline of nanoscience has resulted in a number of new technologies. These groundbreaking advances are firing the imagination of a generation of scientists and leading to new materials with a wealth of functionality. In the biomedical sciences these technological advances are finally...
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
New York, NY [u.a.]
Springer
2013
|
| Schlagworte: | |
| Online-Zugang: | FAN01 UBT01 Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
MARC
| LEADER | 00000nmm a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV041466411 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 131209s2013 |||| o||u| ||||||eng d | ||
| 020 | |a 9781461491644 |c Online |9 978-1-4614-9164-4 | ||
| 024 | 7 | |a 10.1007/978-1-4614-9164-4 |2 doi | |
| 035 | |a (OCoLC)864738650 | ||
| 035 | |a (DE-599)BSZ398201439 | ||
| 040 | |a DE-604 |b ger | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-703 |a DE-1102 | ||
| 050 | 0 | |a RM1-950 | |
| 082 | 0 | |a 615 | |
| 245 | 1 | 0 | |a Fundamentals of Pharmaceutical Nanoscience |c Ijeoma F. Uchegbu ; Andreas G. Schätzlein ; Woei Ping Cheng ; Aikaterini Lalatsa, ed. |
| 264 | 1 | |a New York, NY [u.a.] |b Springer |c 2013 | |
| 300 | |a 1 Online-Ressource | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 520 | |a The emerging discipline of nanoscience has resulted in a number of new technologies. These groundbreaking advances are firing the imagination of a generation of scientists and leading to new materials with a wealth of functionality. In the biomedical sciences these technological advances are finally translating into clinically relevant products and bringing patients exciting new therapies and diagnostics. This is the first book of its kind that seeks to present the application of nanoscience to medicines development - pharmaceutical nanoscience in one accessible volume. The nanotechnologies that derive from pharmaceutical nanoscience are just beginning to make their mark. The book spans the chemistries, which are harnessed to create the materials, the concepts upon which their application rests and model examples of the exploitation of this new knowledge to bring healthcare benefits. A final chapter on the commercialisation pathways taken by these new technologies provides a fitting end to the book as all science is geared towards new knowledge or an improved quality of life through the creation of new interventions, products or services. The book is designed to introduce undergraduates to the technologies underpinning these emerging and existing products, provide a reference volume for graduate scholars seeking an introduction to the fields of pharmaceutical nanoscience and pharmaceutical nanotechnology and provide the expert with accessible information on complementary areas satellite to their main areas of expertise. | ||
| 520 | |a Professor Ijeoma F. Uchegbu Ijeoma Uchegbu is Professor of Pharmaceutical Nanoscience at the UCL School of Pharmacy, University College London and Chief Scientific Officer of Nanomerics, a spin out company from the UCL School of Pharmacy in London. She obtained her PhD from the School of Pharmacy, University of London in 1994, was appointed to a lectureship within the Department of Pharmaceutical Sciences, Strathclyde University in 1997 and a Chair in Drug Delivery at Strathclyde University in 2002. In 2006 Ijeoma was appointed to the Chair in Pharmaceutical Nanoscience at the School of Pharmacy and in 2010 Ijeoma founded Nanomerics with Andreas G. Schätzlein. Nanomerics is a speciality pharmaceutical company focused on exploiting pharmaceutical nanotechnology platforms (http://www.nanomerics.com/) for medicines development | ||
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Medicine | |
| 650 | 4 | |a Toxicology | |
| 650 | 4 | |a Biotechnology | |
| 650 | 4 | |a Chemistry, Physical organic | |
| 650 | 4 | |a Polymers | |
| 650 | 4 | |a Pharmacy | |
| 650 | 4 | |a Nanotechnology | |
| 650 | 4 | |a Biomedicine | |
| 650 | 0 | 7 | |a Pharmazie |0 (DE-588)4045705-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Nanotechnologie |0 (DE-588)4327470-5 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Pharmazie |0 (DE-588)4045705-9 |D s |
| 689 | 0 | 1 | |a Nanotechnologie |0 (DE-588)4327470-5 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Uchegbu, Ijeoma F. |e Sonstige |0 (DE-588)139161112 |4 oth | |
| 700 | 1 | |a Schätzlein, Andreas G. |e Sonstige |4 oth | |
| 700 | 1 | |a Cheng, Woei Ping |e Sonstige |4 oth | |
| 700 | 1 | |a Lalatsa, Aikaterini |e Sonstige |4 oth | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druckausgabe |z 978-1-4614-9163-7 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-1-4614-9164-4 |x Verlag |3 Volltext |
| 912 | |a ZDB-2-SBL | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-026912661 | ||
| 966 | e | |u https://doi.org/10.1007/978-1-4614-9164-4 |l FAN01 |p ZDB-2-SBL |x Verlag |3 Volltext | |
| 966 | e | |u https://doi.org/10.1007/978-1-4614-9164-4 |l UBT01 |p ZDB-2-SBL |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804151599392620544 |
|---|---|
| any_adam_object | |
| author_GND | (DE-588)139161112 |
| building | Verbundindex |
| bvnumber | BV041466411 |
| callnumber-first | R - Medicine |
| callnumber-label | RM1-950 |
| callnumber-raw | RM1-950 |
| callnumber-search | RM1-950 |
| callnumber-sort | RM 11 3950 |
| callnumber-subject | RM - Therapeutics and Pharmacology |
| collection | ZDB-2-SBL |
| ctrlnum | (OCoLC)864738650 (DE-599)BSZ398201439 |
| dewey-full | 615 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615 |
| dewey-search | 615 |
| dewey-sort | 3615 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| doi_str_mv | 10.1007/978-1-4614-9164-4 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04360nmm a2200577 c 4500</leader><controlfield tag="001">BV041466411</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">131209s2013 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781461491644</subfield><subfield code="c">Online</subfield><subfield code="9">978-1-4614-9164-4</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-1-4614-9164-4</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)864738650</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BSZ398201439</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-703</subfield><subfield code="a">DE-1102</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM1-950</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Fundamentals of Pharmaceutical Nanoscience</subfield><subfield code="c">Ijeoma F. Uchegbu ; Andreas G. Schätzlein ; Woei Ping Cheng ; Aikaterini Lalatsa, ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York, NY [u.a.]</subfield><subfield code="b">Springer</subfield><subfield code="c">2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The emerging discipline of nanoscience has resulted in a number of new technologies. These groundbreaking advances are firing the imagination of a generation of scientists and leading to new materials with a wealth of functionality. In the biomedical sciences these technological advances are finally translating into clinically relevant products and bringing patients exciting new therapies and diagnostics. This is the first book of its kind that seeks to present the application of nanoscience to medicines development - pharmaceutical nanoscience in one accessible volume. The nanotechnologies that derive from pharmaceutical nanoscience are just beginning to make their mark. The book spans the chemistries, which are harnessed to create the materials, the concepts upon which their application rests and model examples of the exploitation of this new knowledge to bring healthcare benefits. A final chapter on the commercialisation pathways taken by these new technologies provides a fitting end to the book as all science is geared towards new knowledge or an improved quality of life through the creation of new interventions, products or services. The book is designed to introduce undergraduates to the technologies underpinning these emerging and existing products, provide a reference volume for graduate scholars seeking an introduction to the fields of pharmaceutical nanoscience and pharmaceutical nanotechnology and provide the expert with accessible information on complementary areas satellite to their main areas of expertise.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Professor Ijeoma F. Uchegbu Ijeoma Uchegbu is Professor of Pharmaceutical Nanoscience at the UCL School of Pharmacy, University College London and Chief Scientific Officer of Nanomerics, a spin out company from the UCL School of Pharmacy in London. She obtained her PhD from the School of Pharmacy, University of London in 1994, was appointed to a lectureship within the Department of Pharmaceutical Sciences, Strathclyde University in 1997 and a Chair in Drug Delivery at Strathclyde University in 2002. In 2006 Ijeoma was appointed to the Chair in Pharmaceutical Nanoscience at the School of Pharmacy and in 2010 Ijeoma founded Nanomerics with Andreas G. Schätzlein. Nanomerics is a speciality pharmaceutical company focused on exploiting pharmaceutical nanotechnology platforms (http://www.nanomerics.com/) for medicines development</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Toxicology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biotechnology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Chemistry, Physical organic</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Polymers</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nanotechnology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biomedicine</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazie</subfield><subfield code="0">(DE-588)4045705-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Nanotechnologie</subfield><subfield code="0">(DE-588)4327470-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Pharmazie</subfield><subfield code="0">(DE-588)4045705-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Nanotechnologie</subfield><subfield code="0">(DE-588)4327470-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Uchegbu, Ijeoma F.</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)139161112</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schätzlein, Andreas G.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cheng, Woei Ping</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lalatsa, Aikaterini</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druckausgabe</subfield><subfield code="z">978-1-4614-9163-7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-1-4614-9164-4</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SBL</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-026912661</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-4614-9164-4</subfield><subfield code="l">FAN01</subfield><subfield code="p">ZDB-2-SBL</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-4614-9164-4</subfield><subfield code="l">UBT01</subfield><subfield code="p">ZDB-2-SBL</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV041466411 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T00:57:23Z |
| institution | BVB |
| isbn | 9781461491644 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-026912661 |
| oclc_num | 864738650 |
| open_access_boolean | |
| owner | DE-703 DE-1102 |
| owner_facet | DE-703 DE-1102 |
| physical | 1 Online-Ressource |
| psigel | ZDB-2-SBL |
| publishDate | 2013 |
| publishDateSearch | 2013 |
| publishDateSort | 2013 |
| publisher | Springer |
| record_format | marc |
| spelling | Fundamentals of Pharmaceutical Nanoscience Ijeoma F. Uchegbu ; Andreas G. Schätzlein ; Woei Ping Cheng ; Aikaterini Lalatsa, ed. New York, NY [u.a.] Springer 2013 1 Online-Ressource txt rdacontent c rdamedia cr rdacarrier The emerging discipline of nanoscience has resulted in a number of new technologies. These groundbreaking advances are firing the imagination of a generation of scientists and leading to new materials with a wealth of functionality. In the biomedical sciences these technological advances are finally translating into clinically relevant products and bringing patients exciting new therapies and diagnostics. This is the first book of its kind that seeks to present the application of nanoscience to medicines development - pharmaceutical nanoscience in one accessible volume. The nanotechnologies that derive from pharmaceutical nanoscience are just beginning to make their mark. The book spans the chemistries, which are harnessed to create the materials, the concepts upon which their application rests and model examples of the exploitation of this new knowledge to bring healthcare benefits. A final chapter on the commercialisation pathways taken by these new technologies provides a fitting end to the book as all science is geared towards new knowledge or an improved quality of life through the creation of new interventions, products or services. The book is designed to introduce undergraduates to the technologies underpinning these emerging and existing products, provide a reference volume for graduate scholars seeking an introduction to the fields of pharmaceutical nanoscience and pharmaceutical nanotechnology and provide the expert with accessible information on complementary areas satellite to their main areas of expertise. Professor Ijeoma F. Uchegbu Ijeoma Uchegbu is Professor of Pharmaceutical Nanoscience at the UCL School of Pharmacy, University College London and Chief Scientific Officer of Nanomerics, a spin out company from the UCL School of Pharmacy in London. She obtained her PhD from the School of Pharmacy, University of London in 1994, was appointed to a lectureship within the Department of Pharmaceutical Sciences, Strathclyde University in 1997 and a Chair in Drug Delivery at Strathclyde University in 2002. In 2006 Ijeoma was appointed to the Chair in Pharmaceutical Nanoscience at the School of Pharmacy and in 2010 Ijeoma founded Nanomerics with Andreas G. Schätzlein. Nanomerics is a speciality pharmaceutical company focused on exploiting pharmaceutical nanotechnology platforms (http://www.nanomerics.com/) for medicines development Medizin Medicine Toxicology Biotechnology Chemistry, Physical organic Polymers Pharmacy Nanotechnology Biomedicine Pharmazie (DE-588)4045705-9 gnd rswk-swf Nanotechnologie (DE-588)4327470-5 gnd rswk-swf Pharmazie (DE-588)4045705-9 s Nanotechnologie (DE-588)4327470-5 s DE-604 Uchegbu, Ijeoma F. Sonstige (DE-588)139161112 oth Schätzlein, Andreas G. Sonstige oth Cheng, Woei Ping Sonstige oth Lalatsa, Aikaterini Sonstige oth Erscheint auch als Druckausgabe 978-1-4614-9163-7 https://doi.org/10.1007/978-1-4614-9164-4 Verlag Volltext |
| spellingShingle | Fundamentals of Pharmaceutical Nanoscience Medizin Medicine Toxicology Biotechnology Chemistry, Physical organic Polymers Pharmacy Nanotechnology Biomedicine Pharmazie (DE-588)4045705-9 gnd Nanotechnologie (DE-588)4327470-5 gnd |
| subject_GND | (DE-588)4045705-9 (DE-588)4327470-5 |
| title | Fundamentals of Pharmaceutical Nanoscience |
| title_auth | Fundamentals of Pharmaceutical Nanoscience |
| title_exact_search | Fundamentals of Pharmaceutical Nanoscience |
| title_full | Fundamentals of Pharmaceutical Nanoscience Ijeoma F. Uchegbu ; Andreas G. Schätzlein ; Woei Ping Cheng ; Aikaterini Lalatsa, ed. |
| title_fullStr | Fundamentals of Pharmaceutical Nanoscience Ijeoma F. Uchegbu ; Andreas G. Schätzlein ; Woei Ping Cheng ; Aikaterini Lalatsa, ed. |
| title_full_unstemmed | Fundamentals of Pharmaceutical Nanoscience Ijeoma F. Uchegbu ; Andreas G. Schätzlein ; Woei Ping Cheng ; Aikaterini Lalatsa, ed. |
| title_short | Fundamentals of Pharmaceutical Nanoscience |
| title_sort | fundamentals of pharmaceutical nanoscience |
| topic | Medizin Medicine Toxicology Biotechnology Chemistry, Physical organic Polymers Pharmacy Nanotechnology Biomedicine Pharmazie (DE-588)4045705-9 gnd Nanotechnologie (DE-588)4327470-5 gnd |
| topic_facet | Medizin Medicine Toxicology Biotechnology Chemistry, Physical organic Polymers Pharmacy Nanotechnology Biomedicine Pharmazie Nanotechnologie |
| url | https://doi.org/10.1007/978-1-4614-9164-4 |
| work_keys_str_mv | AT uchegbuijeomaf fundamentalsofpharmaceuticalnanoscience AT schatzleinandreasg fundamentalsofpharmaceuticalnanoscience AT chengwoeiping fundamentalsofpharmaceuticalnanoscience AT lalatsaaikaterini fundamentalsofpharmaceuticalnanoscience |